TRAVERE THERAPEUTICS, INC. Deferred Tax Assets, Net
TRAVERE THERAPEUTICS, INC. (TVTX) had Deferred Tax Assets, Net of $4.85 million as of 2017-09-30, per its 10-Q filed 2017-11-07.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net
us-gaap:DeferredTaxAssetsLiabilitiesNet · last filed 2017-11-07
- 2017-09-30: Deferred Tax Assets, Net $4.85M.
- 2016-12-31: Deferred Tax Assets, Net $0.00.
- 2014-12-31: Deferred Tax Assets, Net -$141.00.
- 2013-12-31: Deferred Tax Assets, Net -$2.60K.
| Period end | Deferred Tax Assets, Net |
|---|---|
| 2017-09-30 | $4.85M 10-Q · filed 2017-11-07 |
| 2016-12-31 | $0.00 10-Q · filed 2017-11-07 |
| 2014-12-31 | -$141.00 10-K · filed 2015-03-11 |
| 2013-12-31 | -$2.60K 10-K · filed 2015-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |